BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting

    NEXT STORY
    Vaccine fra Janssen og Bavarian Nordic introduceres i Rwanda til at styrke beredskabet mod ebola
    PREV STORY
    Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    New number of shares and votes in Oasmia Pharmaceutical AB (publ)

    author_avatar
    NASDAQ Market News

    Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018

    BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing ...

    author_avatar
    NASDAQ Market News

    Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018

    Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018 Amsterdam, ...

    author_avatar
    NASDAQ Market News